In India, an outbreak of the Nipah virus, a severe pathogen causing fever and brain inflammation with a high mortality rate, has alarmed health authorities and neighboring countries. As of late December 2025, two health workers were confirmed to be infected in West Bengal, leading to increased vigilance among adjacent nations. Countries like Pakistan and Vietnam have mandated health screenings for travelers, especially those arriving from the affected regions to prevent potential spread. Pakistan's Border Health Services emphasized the importance of robust surveillance measures, highlighting that travelers are required to disclose their transit histories to identify any recent visit to high-risk areas. The Nipah virus is known for its severe consequences, with a mortality range between 40% and 75%. Although it is primarily transmitted from animals, particularly fruit bats, to humans through direct contact, its person-to-person transmission is not common. Indian health officials maintain that there is no widespread outbreak, suggesting that the cases identified are contained, as they have traced numerous contacts linked to the infected individuals who have shown no symptoms. They reassured the public that the situation in India is under control and that there was no immediate need for airport screenings within the country itself. The World Health Organization lists Nipah as a priority pathogen due to its potential for outbreaks and the absence of an available vaccine. Historically, Nipah was first identified during a 1998 outbreak among pig farmers in Malaysia and Singapore. Since then, sporadic cases have occurred primarily in India, especially in the south where conditions have allowed the virus to thrive. The Coalition for Epidemic Preparedness Innovations is currently funding a vaccine trial aiming to combat this lethal virus, reflecting a concerted effort to address the potential risk it poses not only regionally but globally given its past outbreaks. While precautions are being emphasized in high-risk areas, experts maintain that the general risk of a global outbreak remains low as Nipah does not spread as easily as other infectious diseases like COVID-19. This situation highlights the delicate balance of public health management in the face of emerging infections and the importance of alertness, particularly for travelers who might unknowingly carry diseases between countries. The actions taken by neighboring countries affirm their commitment to protecting their populations while navigating the challenges posed by infectious disease outbreaks.

Nipah virus is a zoonotic virus that can cause severe disease in both humans and animals. It was first identified during an outbreak in Malaysia in 1998-1999, linked to pig farmers who were in contact with infected animals. The virus is believed to be transmitted from bats, particularly fruit bats, to domestic pigs, and can then be spread to humans through close contact with infected animals or their bodily fluids. Since its initial emergence, Nipah virus outbreaks have been reported in several countries, predominantly in Bangladesh and India, leading to significant morbidity and mortality. The WHO reported a case fatality rate that can range from 40% to 75%, depending on the outbreak and the effectiveness of the response measures implemented. The clinical presentation of Nipah virus infection in humans varies widely, ranging from asymptomatic cases to severe encephalitis and acute respiratory distress. The incubation period is typically between 5 to 14 days, after which patients may initially experience fever, headache, and myalgia, followed by the onset of neurological symptoms such as confusion, seizures, and altered consciousness. In some instances, patients may develop severe acute respiratory syndrome, adding to the complexity of the disease. Prompt diagnosis is crucial, as the clinical signs can mimic those of other viral infections, such as influenza or dengue fever. Nipah virus is a public health concern due to its potential to cause outbreaks and its ability to be transmitted between humans. In response to outbreaks, health authorities have implemented various control measures, including community awareness campaigns, monitoring bat populations, and conducting epidemiological studies to elucidate transmission dynamics. The development of vaccines and antiviral treatments is ongoing, but as of now, there is no specific treatment for Nipah virus infection, underscoring the need for continued research and public health preparedness. The history of Nipah virus outbreaks highlights the importance of surveillance systems for early detection and rapid response. The need for a coordinated approach involving veterinary and public health sectors is essential in addressing potential spillover events from wildlife to domestic animals and humans. Enhanced understanding of the virus ecology and epidemiology will be critical in informing prevention strategies. As the world becomes increasingly interconnected and environmental changes continue to alter patterns of animal-human interactions, the risk of future Nipah virus outbreaks remains a significant concern for global health security.